SCHEMBL10180445

SCHEMBL10180445

Oc1ccc(-c2ccc3ncc(N4CCN(Cc5ccccc5)CC4)nc3c2)cc1.Oc1ccc(-c2ccc3ncc(N4CCc5ccccc5C4)nc3c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
DRD4 P21917 1/20 0.42
HCAR2 Q8TDS4 1/20 0.41
GRIN2D O15399 2/20 0.39
GRIN3B O60391 2/20 0.39
GRIN1 Q05586 2/20 0.39
GRIN2A Q12879 2/20 0.39
GRIN2B Q13224 2/20 0.39
GRIN2C Q14957 2/20 0.39
GRIN3A Q8TCU5 2/20 0.39
RET P07949 1/20 0.39
CASP1 P29466 1/20 0.39
CASP5 P51878 1/20 0.39
HCRTR1 O43613 1/20 0.39
HCRTR2 O43614 1/20 0.39
HDAC1 Q13547 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12812478 0.91 NPC1 (0.68) NPC1RAB9AALDH1A1KDM4EPOLB
SCHEMBL12812471 0.88 GRIN2D (0.45) HCAR2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL12812477 0.87 NPC1 (0.63) NPC1RAB9AALDH1A1KDM4EPOLB
SCHEMBL1443527 0.81 NPC1 (0.54) NPC1RAB9AALDH1A1KDM4EPOLB
SCHEMBL12812429 0.81 NPC1 (0.53) NPC1RAB9AALDH1A1KDM4EPOLB
SCHEMBL12812480 0.81 NPC1 (0.53) NPC1RAB9AALDH1A1KDM4EPOLB
SCHEMBL12812430 0.80 NPC1 (0.53) NPC1RAB9AALDH1A1KDM4EPOLB
SCHEMBL10180907 0.80 NPC1 (0.52) NPC1RAB9AALDH1A1KDM4EPOLB
SCHEMBL10179172 0.79 NPC1 (0.63) NPC1RAB9AALDH1A1KDM4EPOLB
SCHEMBL1442598 0.79 NPC1 (0.51) NPC1RAB9APOLBDRD4HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2473498-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS Bayer Pharma Aktiengesellschaft (DE) 2012-07-11 EP claimed